Comparison Chart Scholar Rock Holding Corporation
Stocks
SRRK
US80706P1030
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
04:00:00 22/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 56.50 USD | +2.26% |
|
+7.58% | +28.26% |
| 08-22 | Scholar Rock's Global Regulatory Path Further De-Risked, Wedbush Says | MT |
| 08-22 | Wedbush Adjusts Scholar Rock Price Target to $64 From $58, Maintains Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Bio Therapeutic Drugs | +2.26% | +7.58% | +28.26% | +59.20% | +46.37% | 6.88B |  |  | |
- Stock Market
- Stocks
- SRRK Stock
- Charts Scholar Rock Holding Corporation
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
